Physician profile
John E Francis
NPI 1306814496
$34,916.02
in general payments reported to CMS, 2019-2025
15 companies · $4,217 in 2025
The $4,217 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $2,311 · 2021: $3,139 · 2022: $2,843 · 2023: $4,259 · 2024: $224 · 2025: $4,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $700.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,161.69 | 2019-2025 | Da Vinci Surgical System |
| Cook Biotech Incorporated | $9,149.34 | 2019-2022 | |
| Cook Research Incorporated | $2,000.00 | 2019 | |
| Davol INC. | $257.95 | 2023-2024 | Phasix Mesh |
| Sanara Medtech INC. | $101.01 | 2021-2022 | |
| Braintree Laboratories, INC. | $42.70 | 2025 | Sutab, Suflave |
| Sumitomo Pharma America, INC. | $39.78 | 2024 | Orgovyx |
| Procept Biorobotics Corporation | $30.28 | 2022 | |
| Astellas Pharma US INC | $24.68 | 2025 | Xtandi |
| Sun Pharmaceutical Industries INC. | $22.35 | 2022 | |
| Tolmar, INC. | $20.54 | 2024 | |
| Cook Medical LLC | $18.50 | 2019 | |
| Hollister Incorporated | $17.91 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.84 | 2023 | Zilretta, Exparel, Iovera |
| Boston Scientific Corporation | $14.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.